Generic version of HIV prevention drug on way after activist campaign


Gilead Sciences, makers of HIV prevention drug Truvada, have announced that a generic version will be available as early as September 2020. Truvada, also called PrEP, is a daily pill that prevents those who take the drug from transmitting to their partner. “Gilead reached an agreement with Teva Pharmaceuticals in 2014 to allow the early…

from Living | New York Post https://nyp.st/2YhvmVp